Oncology

After being diagnosed with stage 2-3 cancer shortly after her mother, 46-year-old mother of seven Leah Shops shares her inspiring journey of early detection, family resilience, and community support.

Researchers developed an AI system that predicts cancer survival and biological age from a single facial photo, analyzing specific facial regions to assist oncologists in treatment decisions.

Breast cancer presents significant financial challenges alongside health hurdles. Attorney Sheri Dvir outlines key steps for managing income loss, insurance claims, and state benefits.

A 38-year-old fitness instructor from Petah Tikva was diagnosed with breast cancer five months postpartum after mentioning a lump to her pediatrician, highlighting the vital importance of early detection.

A comprehensive genetic study analyzing over 150,000 tumor samples reveals key insights into brain metastases, highlighting high mutational burden and shared pathways.

U.S. health advisers voted to support Grail's Galleri blood test for multi-cancer early detection, balancing potential benefits against accuracy concerns.

A new study from Griffith University explores breath testing technologies to distinguish between benign and malignant lung nodules, potentially reducing invasive biopsies.

Israeli doctors share their harrowing personal experiences of balancing medical careers and the treatment of their young children diagnosed with aggressive pediatric cancers.

According to the Israel Cancer Association's estimate, about 5,870 women in Israel are expected to be diagnosed with the disease by the end of 2026. New studies have found a link between night shifts and increased risk, while weight-loss injections and physical activity have been linked to reduced risk. The forecast for the coming years points to a further increase in the number of those diagnosed...

Oncologists have ranked the preferred treatments for the 2027 health basket, including drugs for bladder, stomach, and breast cancer, and a treatment that may eliminate the need for surgery and radiation in rectal cancer. Experts warn: the gap between treatments in public medicine and those available through private insurance is deepening.

Former Knesset member and journalist Shelly Yachimovich published an update on her condition and answered questions from the public. She explained how the tumor was diagnosed at an early stage and clarified that the new pancreatic cancer drug is not currently relevant for her.

The US Food and Drug Administration (FDA) has approved a new drug, Rasonque, for the treatment of advanced pancreatic cancer. Experts believe this development could significantly improve outcomes for patients facing this deadly disease.

Data collected over decades reveals that daily consumption of sugary drinks increases the risk of developing the disease by two and a half times. These are the surprising findings discovered regarding diet versions.

The company, traded on NASDAQ and focused on urinary tract cancer treatments, has announced a collaboration agreement with the Israeli firm Intragel, which has developed a biodegradable gel for the sustained release of drugs.

Researchers have identified previously unknown immune structures within the skull bone marrow that act as a local brain defense center. The study, published in Nature, could lead to new treatments for brain tumors and neurological conditions.

15-year-old Mark was diagnosed with a rare bone cancer that spread to his pelvis and lungs, and the tumor was initially defined as inoperable. After chemotherapy and extensive planning, teams from Schneider and Beilinson performed a 19-hour surgery to remove it and reconstruct the pelvis using an implant tailored to his body. He is now continuing the rehabilitation process: "Cases that were...

An experimental personalized cancer vaccine from Merck and Moderna has shown positive preliminary results in a Phase 3 trial. The combination therapy significantly reduced the risk of melanoma recurrence.

An experimental personalized cancer vaccine for melanoma from Merck and Moderna has shown positive preliminary results in its first late-stage trial. The combination therapy significantly extended the time patients lived without recurrence.

The treatment of multiple myeloma has changed dramatically in recent years. Following research and therapeutic breakthroughs, it is time to debunk some of the most common myths about the disease.

A bad landing during a pickleball game led 27-year-old fitness trainer Nick Page to a life-altering diagnosis: undifferentiated pleomorphic sarcoma, a rare and aggressive bone cancer. After months of uncertainty, Page underwent complex surgery and 27 weeks of intensive chemotherapy, ultimately finding a new perspective on health and gratitude.

A new drug, iberdomide (Zanvexus), has been approved by the FDA for the treatment of adults with relapsed or refractory multiple myeloma. Its combination with other drugs nearly doubled the rate of patients in whom no evidence of the disease was found. It is still unclear whether this will translate into extended life. Dr. Julia Vaksman, from the Hematology Department at the Davidoff Center in...

Rob, a resident of England, felt perfectly healthy until the 'Galleri' blood test—a screening tool for early cancer detection—twice flagged a potential issue. Subsequent examinations revealed stage 1 cancer at the base of his tongue. How does this test work, who is it for, and how can it be accessed in Israel?

The absence of breast cancer cases in the family does not guarantee low risk, and most patients are diagnosed without a significant family history. Alongside mammography and familiarity with changes in the body, experts call for tailoring monitoring to the individual risk level. Prof. Tanir Allweis, Director of the Breast Health System and Director of the Breast Surgery Department at Hadassah...

Preliminary findings from a first-of-its-kind Israeli study led by Beilinson Medical Center highlight long-term impacts of testicular cancer: over 60% of survivors report psychological effects, 41% report erectile dysfunction, and 66% of those who did not preserve sperm regret the decision. "It is not enough for the patient to recover; it is important to understand how to preserve his quality of...

New hope for patients with recurrent glioblastoma: Hadassah Medical Center in Ein Kerem has begun, for the first time in Israel, treating recurrent brain tumors using alpha radiation delivered directly into the tumor. The experimental procedure was performed on a 77-year-old patient as part of a clinical study.

An innovative surgery performed at the Wolfson Medical Center may mark a breakthrough in the treatment of rare bone tumors: a multidisciplinary team removed a malignant tumor from the arm of a 41-year-old patient and reconstructed her shoulder using a 3D-printed implant specifically tailored to her body structure. According to the hospital, this is the first time in Israel that this technology has...

Can a lung transplant, a procedure that for years was hardly considered an option for patients with advanced lung cancer, become a treatment for a specific group of patients? A study published in the medical journal JAMA presents exceptional preliminary results among patients with stage 4 NSCLC lung cancer, whose disease was limited to the lungs and did not respond to medical treatment.

Adi Schneider-Dori, a mother of three from Kibbutz Revadim, turned to doctors when she could not breastfeed from her left breast. They reassured her that it was just an infection. Until she reached Dr. Orly Friedman-Aldar, a senior breast surgeon at Kaplan, and then the red lights went on: "An infection can only develop during breastfeeding, so it was immediately suspicious."

How much does PSA need to drop to know that prostate cancer treatment is really working? A new study published today (Monday) in the journal CANCER of the American Cancer Society points to a clear target: a PSA level lower than 0.2 ng/mL within nine months of starting treatment was associated with better survival among patients with metastatic hormone-sensitive prostate cancer.

After two years of misdiagnosis, 15 rounds of chemotherapy, and three surgeries, 12-year-old Noa Piruz's disease has spread to her lungs, and doctors in Israel have run out of options. Now, there are only a few days left to fly her for innovative treatment abroad. Her parents state: "We promised we wouldn't give up, we need help."

Significant news in the fight against one of the deadliest cancers: a new oral drug has nearly doubled the median survival of patients with metastatic pancreatic cancer who had already received prior treatment, compared to standard chemotherapy. The drug, Daraxonrasib (RMC-6236), was tested in a phase 3 study called RASolute 302, showing a median overall survival of 13.2 months versus 6.7 months...

A festive event marking the renewal and renovation of the pediatric hemato-oncology department was held at the Sheba Medical Center in Tel HaShomer. The project was carried out as part of the activities of the 'Rachashei Lev' organization and thanks to the donation of Yossi Dahan.

A patient who underwent several unsuccessful rounds of treatment has received therapy based on engineering his own immune system cells. The process involves collecting cells from the patient's blood, re-engineering them, and returning them to the body to fight the tumor.

Personalized medicine is considered one of the most promising fields in oncology, and one of the largest projects in the field is now underway. Researchers, supported by the U.S. National Institutes of Health (NIH), have announced the creation of a comprehensive repository of human cancer tumor models, collected from thousands of patients and representing 25 different types of cancer. The project...

The Israeli Ministry of Health has released the 2023 report from the National Center for Disease Control. While the absolute number of diagnoses has risen due to population growth, age-adjusted incidence rates continue to show a steady downward trend.

Researchers at the University of Pennsylvania have developed an engineered chewing gum that targets microorganisms associated with head and neck cancers. The treatment eliminates harmful bacteria without damaging the mouth's natural, beneficial microbiome.

New studies raise the possibility that drugs from the GLP-1 family, used to treat obesity and diabetes, may reduce the risk of breast cancer recurrence. However, at this stage, these are observational findings only.

On World Lung Cancer Day, experts at Ziv Medical Center highlight the dangers of this disease. Despite medical advancements, mortality remains high due to late-stage diagnosis.

The Tel Aviv Sourasky Medical Center (Ichilov) and the Israeli biotech company Silenseed have launched a clinical trial for the drug SIL204. This innovative treatment targets the KRAS gene mutation, potentially marking a breakthrough in treating one of the deadliest forms of cancer.

Gali Sagi, the mother of the late Niv Haya, who passed away from cancer, appeared on 'Israel HaBoker' to discuss the book she wrote during her daughter's treatment in Texas. "It took on a completely different meaning when she passed away; she managed to hold it in her hand literally a week before. She was unconscious and I read chapters to her," she shared.

A new drug successfully blocks a protein considered one of the main growth drivers of pancreatic cancer, extending the lives of patients who have exhausted standard treatment options.

The reality star shared with her followers that, following her past illness, a new pregnancy could significantly endanger her health and that of the fetus: "I would very much like to, but at the moment I don't have the option because of my health."

About 70% of children recovering from cancer do not receive essential rehabilitation treatments on time due to a shortage of therapists and available appointments. Long waiting times, distance from rehabilitation centers, and a lack of adapted solutions burden families and harm the recovery process.